Total Payments
$1,306
2024 Payments
$248.46
Companies
20
Transactions
64
Medicare Patients
6,302
Medicare Billing
$878,374
Payment Breakdown by Category
Food & Beverage$1,284 (98.3%)
Other$22.02 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,284 | 63 | 98.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $22.02 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $407.21 | 20 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $157.28 | 7 | $0 (2024) |
| GENZYME CORPORATION | $141.46 | 5 | $0 (2022) |
| Amgen Inc. | $121.31 | 5 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $77.95 | 4 | $0 (2024) |
| LEO Pharma Inc. | $68.15 | 4 | $0 (2022) |
| Janssen Biotech, Inc. | $41.26 | 2 | $0 (2024) |
| PFIZER INC. | $38.38 | 2 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $35.92 | 2 | $0 (2022) |
| Novo Nordisk Inc | $32.53 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248.46 | 11 | Regeneron Healthcare Solutions, Inc. ($57.38) |
| 2023 | $62.77 | 4 | Novo Nordisk Inc ($17.21) |
| 2022 | $539.26 | 25 | ABBVIE INC. ($234.11) |
| 2021 | $259.83 | 12 | AbbVie Inc. ($112.59) |
| 2020 | $29.46 | 2 | AbbVie Inc. ($29.46) |
| 2019 | $39.69 | 2 | Amgen Inc. ($23.33) |
| 2018 | $57.41 | 4 | Novartis Pharmaceuticals Corporation ($30.58) |
| 2017 | $69.55 | 4 | GENZYME CORPORATION ($31.32) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| Category: Hematology/Oncology | ||||||
| 10/07/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Oncology | ||||||
| 10/01/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 09/30/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: ONCOLOGY | ||||||
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Immunology | ||||||
| 06/27/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Diabetes | ||||||
| 06/27/2023 | Ultragenyx Pharmaceutical Inc. | CRYSVITA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 04/19/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Neurology | ||||||
| 10/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: IMMUNOLOGY | ||||||
| 05/24/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: Immunology | ||||||
| 05/19/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2022 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: DERMATOLOGY | ||||||
| 04/21/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: DERMATOLOGY | ||||||
| 04/20/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: Inflammation | ||||||
| 04/19/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 579 | 914 | $93,673 | $27,439 |
| 2022 | 19 | 1,343 | 1,830 | $769,780 | $175,608 |
| 2021 | 24 | 2,206 | 3,166 | $1.4M | $330,966 |
| 2020 | 23 | 2,174 | 3,112 | $1.8M | $344,362 |
Total Patients
6,302
Total Services
9,022
Medicare Billing
$878,374
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 71 | 93 | $17,112 | $6,429 | 37.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 96 | 96 | $17,856 | $4,947 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 83 | 94 | $11,647 | $4,513 | 38.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 72 | 91 | $13,832 | $3,243 | 23.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Facility | 2023 | 93 | 93 | $11,894 | $3,054 | 25.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 27 | 31 | $6,448 | $1,527 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $4,845 | $1,450 | 29.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 40 | 44 | $3,300 | $1,132 | 34.3% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 27 | 29 | $2,175 | $658.80 | 30.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 53 | 326 | $4,564 | $484.81 | 10.6% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 93 | 125 | $176,375 | $60,703 | 34.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 73 | 118 | $101,244 | $35,888 | 35.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 215 | 236 | $72,452 | $12,868 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 147 | $32,487 | $9,454 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 199 | 212 | $32,341 | $8,913 | 27.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Facility | 2022 | 60 | 72 | $135,936 | $8,692 | 6.4% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 14 | 16 | $20,736 | $7,590 | 36.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 109 | 187 | $30,855 | $6,521 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 58 | 58 | $22,330 | $5,000 | 22.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 128 | 147 | $30,576 | $4,252 | 13.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Facility | 2022 | 28 | 31 | $21,359 | $2,584 | 12.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $15,064 | $2,480 | 16.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 29 | 31 | $8,556 | $1,886 | 22.0% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Facility | 2022 | 15 | 15 | $9,180 | $1,769 | 19.3% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Facility | 2022 | 12 | 12 | $28,656 | $1,546 | 5.4% |
About Dr. Igor Siniakov, MD
Dr. Igor Siniakov, MD is a Dermatology healthcare provider based in Columbus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053430272.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Igor Siniakov, MD has received a total of $1,306 in payments from pharmaceutical and medical device companies, with $248.46 received in 2024. These payments were reported across 64 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,284).
As a Medicare-enrolled provider, Siniakov has provided services to 6,302 Medicare beneficiaries, totaling 9,022 services with total Medicare billing of $878,374. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery
- Location Columbus, GA
- Active Since 03/28/2007
- Last Updated 06/12/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1053430272
Products in Payments
- SKYRIZI (Biological) $233.86
- DUPIXENT (Biological) $181.04
- Otezla (Drug) $97.98
- RINVOQ (Biological) $80.82
- LIBTAYO (Biological) $73.74
- ADBRY (Biological) $68.15
- HUMIRA (Biological) $45.27
- EUCRISA (Drug) $38.38
- DERMATITIS - DISEASE (Drug) $31.32
- COSENTYX (Biological) $30.58
- VALCHLOR (Drug) $26.70
- JAKAFI (Drug) $24.45
- KISQALI (Drug) $23.69
- SCEMBLIX (Drug) $23.68
- Otezla (Biological) $23.33
- CARVYKTI (Drug) $22.83
- Ilumya (Biological) $22.02
- NINLARO (Drug) $21.15
- DOPTELET (Drug) $19.53
- RYBREVANT (Drug) $18.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Columbus
Dr. Michael Sheehan, M.d, M.D
Dermatology — Payments: $311,374
Dermatology $311,374
Benjamin Kaffenberger, Md, MD
Dermatology — Payments: $108,563
Dermatology $108,563
Stephanie Fabbro, M.d, M.D
Dermatology — Payments: $78,097
Dermatology $78,097
Dr. Shari Hicks-Graham, M.d, M.D
Dermatology — Payments: $74,753
Dermatology $74,753
Dr. Jessica Kaffenberger, M.d, M.D
Dermatology — Payments: $64,937
Dermatology $64,937
Peter Neidenbach, Md, MD
Dermatology — Payments: $40,935
Dermatology $40,935